• The target trendline in the graph above represents an accepted national benchmark percentile for Medicaid programs across the country. The value graphed historically was the national 50^th percentile for comparison purposes. In 2020 (for measurement year 2019) we modified the value shown to demonstrate a target based on our actual performance.  For this measure, the target is the 25^th national percentile.  Please note that a lower rate is better for this measure.
• The annual reported rate captures activity during the previous calendar year. 
• This is a Pharmacy Quality Alliance (PQA) measure.  PQA performance measures are grouped into the domains of Adherence, Appropriate Medication Use, Medication Safety, and Medication Therapy management.  PQA has two core measure sets focused on opioid prescribing and specialty medications.

Rate per 1,000 Medicaid enrollees age 18 and older without cancer who received prescriptions for opioids with a daily dosage greater than 120 mg morphine equivalent dose (MED) for 90 consecutive days or longer.

Last updated:  August 2021